€100,000 investment opportunity for central nervous system research

News

Author: Parkinson's Life editorsPublished: 6 June 2018

Prep: Cook: Serves:

Zcube, a research venture of Italian pharmaceutical company Zambon, has invited researchers, scientists and aspiring entrepreneurs to apply for its third international Open Accelerator programme.

The programme – which runs for 12 weeks at the Openzone campus in Milan, Italy – will have a specific focus on the therapeutic areas of the central nervous system and the respiratory system, including rare diseases in these two areas. Upon completing the accelerator, participants will have the chance to win seed investment of up to €100,000 to develop their projects in collaboration with Zambon.

Elena Zambon, president of Zambon, said: “Open Accelerator is a fundamental ‘school’ teaching young researchers how to communicate with the business world and venture capitalists and to take their ideas out of the laboratories and let them become effective opportunities to improve patients’ lives.”

Submissions for the accelerator programme are open until 30 June 2018.

To apply for the Open Accelerator programme click here.

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Meet the 17-year-old inventor “treating Parkinson’s from the root”

Student creates a DNA nanorobot for more targeted Parkinson’s treatment

VIDEO: “Children shouldn’t feel isolated or hopeless because a parent has Parkinson’s”

New educational film to support families dealing with Parkinson’s

“I can draw again” – how a smart watch helped a graphic designer overcome her Parkinson’s tremor

Vibrating watch helps graphic designer draw again

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

Students develop wearable device to track Parkinson’s tremors

A wearable device has been developed to monitor Parkinson’s tremors and their severity through the tracking of body movements. The device – Tremor Tracker – was created by two students, Julie Gaudin and Elizabeth Hummel, at Louisiana Tech University, US, as part of a design class project. The students designed an algorithm using data recorded from volunteer participants at Rock Steady, a boxing programme for people with Parkinson’s. They then applied the algorithm to a GENEActiv, a wrist-worn device that has been scientifically validated for clinical research. Hummel, co-creator of the Tremor Tracker, said: “Through supervised machine learning, the device predicts whether a patient’s tremors are parkinsonian or non-parkinsonian, as well as the severity of these tremors. A quantitative analysis of parkinsonian tremors provides a more detailed disease state.”

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

€100,000 investment opportunity for central nervous system research

News

Author: Parkinson's Life editorsPublished: 6 June 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Meet the 17-year-old inventor “treating Parkinson’s from the root”

Resources & Tools

VIDEO: “Children shouldn’t feel isolated or hopeless because a parent has Parkinson’s”

Advances

“I can draw again” – how a smart watch helped a graphic designer overcome her Parkinson’s tremor

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

€100,000 investment opportunity for central nervous system research

News

Author: Parkinson's Life editorsPublished: 6 June 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Meet the 17-year-old inventor “treating Parkinson’s from the root”

Resources & Tools

VIDEO: “Children shouldn’t feel isolated or hopeless because a parent has Parkinson’s”

Advances

“I can draw again” – how a smart watch helped a graphic designer overcome her Parkinson’s tremor

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Sign in